Vratizolin
Latest Information Update: 09 Jul 1998
At a glance
- Originator Glaxo Wellcome SA
- Class Analgesics; Antibacterials; Antifungals; Antivirals; Nonsteroidal anti-inflammatories
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Viral infections
Most Recent Events
- 09 Jul 1998 Polfa Poznan is now called Glaxo Wellcome Poznan
- 09 Oct 1995 Discontinued-Preclinical for Viral infections in Poland (Unknown route)
- 22 Sep 1995 New profile